• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿柏西普治疗并延长方案下黄斑新生血管的长期形态学变化

LONG-TERM MORPHOLOGIC CHANGES IN MACULAR NEOVASCULARIZATION UNDER AFLIBERCEPT TREATMENT WITH A TREAT-AND-EXTEND REGIMEN.

作者信息

Nakano Yuyako, Takeuchi Jun, Horiguchi Etsuyo, Ota Hikaru, Taki Yosuke, Ito Yasuki, Terasaki Hiroko, Nishiguchi Koji M, Kataoka Keiko

机构信息

Department of Ophthalmology, Nagoya University Graduate School of Medicine, Nagoya, Japan; Department of Ophthalmology, Fujita Health University School of Medicine, Toyoake, Japan; and Department of Ophthalmology, Kyorin University Graduate School of Medicine, Tokyo, Japan.

出版信息

Retina. 2023 Mar 1;43(3):412-419. doi: 10.1097/IAE.0000000000003676.

DOI:10.1097/IAE.0000000000003676
PMID:36730570
Abstract

PURPOSE

To examine the morphologic changes in macular neovascularization (MNV) secondary to age-related macular degeneration after 2 years of aflibercept treatment under a treat-and-extend (T&E) regimen.

METHODS

This retrospective study analyzed the medical records for 26 eyes of 25 patients diagnosed with treatment-naive neovascular age-related macular degeneration and treated with aflibercept under a treat-and-extend regimen for 2 years. The areas of the MNV and vascular structures were assessed using swept-source optical coherence tomography angiography at baseline and after 2 years of treatment.

RESULTS

The mean MNV area increased significantly from 0.65 ± 0.42 mm 2 at baseline to 0.78 ± 0.45 mm 2 at 2 years. At 2 years, the mean change in the MNV area from baseline was 22% (interquartile range: 4%-60%). The baseline MNV area was negatively correlated with the change ratio of the MNV areas at 2 years and baseline ( R = -0.68, P < 0.001). Nine of the 26 eyes (34.6%) showed newly formed mature vessels, and 7 eyes (26.9%) showed prominently developing preexisting mature vessels.

CONCLUSION

Macular neovascularization expanded and showed vascular maturation under aflibercept treatment with a treat-and-extend regimen. The smaller the MNV at baseline, the greater is its expansion in 2 years.

摘要

目的

在治疗并延长(T&E)方案下,研究阿柏西普治疗2年后年龄相关性黄斑变性继发黄斑新生血管(MNV)的形态学变化。

方法

这项回顾性研究分析了25例初治新生血管性年龄相关性黄斑变性患者的26只眼睛的病历,这些患者在治疗并延长方案下接受阿柏西普治疗2年。在基线期和治疗2年后,使用扫频源光学相干断层扫描血管造影术评估MNV和血管结构的面积。

结果

MNV平均面积从基线时的0.65±0.42mm²显著增加到2年时的0.78±0.45mm²。在2年时,MNV面积相对于基线的平均变化为22%(四分位间距:4%-60%)。基线MNV面积与2年时和基线时MNV面积的变化率呈负相关(R=-0.68,P<0.001)。26只眼中有9只(34.6%)出现新形成的成熟血管,7只眼(26.9%)显示原有成熟血管显著发展。

结论

在治疗并延长方案的阿柏西普治疗下,黄斑新生血管扩张并显示出血管成熟。基线时MNV越小,其在2年内的扩张越大。

相似文献

1
LONG-TERM MORPHOLOGIC CHANGES IN MACULAR NEOVASCULARIZATION UNDER AFLIBERCEPT TREATMENT WITH A TREAT-AND-EXTEND REGIMEN.阿柏西普治疗并延长方案下黄斑新生血管的长期形态学变化
Retina. 2023 Mar 1;43(3):412-419. doi: 10.1097/IAE.0000000000003676.
2
[Prognosis criteria of optical coherence tomography angiography for the long-term efficacy of anti-VEGF therapy of neovascular age-related macular degeneration].[光学相干断层扫描血管造影术对新生血管性年龄相关性黄斑变性抗VEGF治疗长期疗效的预后标准]
Vestn Oftalmol. 2023;139(6):50-58. doi: 10.17116/oftalma202313906150.
3
Quantitative response of macular neovascularisation to loading phase of aflibercept in neovascular age-related macular degeneration.抗血管内皮生长因子治疗新生血管性年龄相关性黄斑变性黄斑新生血管对负荷期的定量反应。
Eye (Lond). 2023 Dec;37(17):3648-3655. doi: 10.1038/s41433-023-02574-0. Epub 2023 May 31.
4
Analyses of the effects of persistent subretinal fluid on visual/anatomic outcomes according to the type of macular neovascularization during the relaxed treat-and-extend protocol in age-related macular degeneration patients.根据年龄相关性黄斑变性患者放松治疗和扩展方案中黄斑新生血管的类型,分析持续性视网膜下液对视觉/解剖结果的影响。
BMC Ophthalmol. 2021 Aug 10;21(1):294. doi: 10.1186/s12886-021-02063-6.
5
Optical coherence tomography angiography patterns of type 1 macular neovascularization in age-related macular degeneration patients.年龄相关性黄斑变性患者1型黄斑新生血管的光学相干断层扫描血管造影模式
Eur J Ophthalmol. 2023 Jul;33(4):1697-1705. doi: 10.1177/11206721221150535. Epub 2023 Jan 4.
6
Using optical coherence tomography angiography in assessment of the anti-vascular endothelial growth factor effect for pathological vascular tissue in age-related macular degeneration and polypoidal choroidal vasculopathy.应用光相干断层扫描血管造影评估抗血管内皮生长因子治疗年龄相关性黄斑变性和息肉状脉络膜血管病变病理性血管组织的效果。
Eur J Ophthalmol. 2021 May;31(3):1267-1280. doi: 10.1177/1120672120913012. Epub 2020 Mar 31.
7
Macular Atrophy in Neovascular Age-Related Macular Degeneration: A Randomized Clinical Trial Comparing Ranibizumab and Aflibercept (RIVAL Study).新生血管性年龄相关性黄斑变性的黄斑萎缩:比较雷珠单抗和阿柏西普的随机临床试验(RIVAL 研究)。
Ophthalmology. 2020 Feb;127(2):198-210. doi: 10.1016/j.ophtha.2019.08.023. Epub 2019 Aug 27.
8
OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY ASSESSMENT OF VASCULAR EFFECTS OCCURRING AFTER AFLIBERCEPT INTRAVITREAL INJECTIONS IN TREATMENT-NAIVE PATIENTS WITH WET AGE-RELATED MACULAR DEGENERATION.光学相干断层扫描血管造影术评估初治湿性年龄相关性黄斑变性患者玻璃体内注射阿柏西普后发生的血管效应
Retina. 2017 Feb;37(2):247-256. doi: 10.1097/IAE.0000000000001145.
9
Macular Atrophy Incidence and Progression in Eyes with Neovascular Age-Related Macular Degeneration Treated with Vascular Endothelial Growth Factor Inhibitors Using a Treat-and-Extend or a Pro Re Nata Regimen: Four-Year Results of the MANEX Study.血管内皮生长因子抑制剂治疗新生血管性年龄相关性黄斑变性的眼内黄斑萎缩发生率和进展:MANEX 研究四年结果。
Ophthalmology. 2020 Dec;127(12):1663-1673. doi: 10.1016/j.ophtha.2020.06.019. Epub 2020 Jun 13.
10
Two-year outcomes of treat-and-extend regimen with intravitreal brolucizumab for treatment-naïve neovascular age-related macular degeneration with type 1 macular neovascularization.治疗初发新生血管性年龄相关性黄斑变性伴 1 型黄斑新生血管的玻璃体腔内 brolucizumab 治疗和延长方案的两年结果。
Sci Rep. 2023 Feb 24;13(1):3249. doi: 10.1038/s41598-023-30146-5.

引用本文的文献

1
Quantitative Evaluation of Type 1 and Type 2 Choroidal Neovascularization Components Under Treatment With Projection-Resolved OCT Angiography.基于分层结构光 OCT 血管造影术对 1 型和 2 型脉络膜新生血管成分的定量评估。
Invest Ophthalmol Vis Sci. 2024 Sep 3;65(11):32. doi: 10.1167/iovs.65.11.32.